Article
CD133, One of the Markers of Cancer Stem Cells in Hep‐2 Cell Line
1 Mar 2007
Abstract excerpt
OBJECTIVE: In recent years, a growing body of evidence has been reported that a tumor clone is organized as a hierarchy that originates from rare stem cells. CD133, a cell surface antigen, was identified as a stem cell maker for human leukemia, brain tumors, and prostate cancer. The purpose of this study was to detect the expression of CD133, a putative marker of cancer stem cells in the Hep-2 cell line, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
